The impact of blood coagulability on atherosclerosis and cardiovascular disease
Aspirin twice a day keeps new COX-1 at bay
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure
von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population
Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis
Performance of age-adjusted D-dimer cut-off to rule out pulmonary embolism
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent
Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure
Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort
Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule
Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes
Making contact with microparticles
Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII
Coagulometer international sensitivity index (ISI) derivation, a rapid method using the prothrombin time/international normalized ratio (PT/INR) Line: a multicenter study
Crystal structure of the native plasminogen reveals an activation-resistant compact conformation
Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III
Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow-based platelet adhesion
Critical von Willebrand factor A1 domain residues influence type VI collagen binding
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease
Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban
Association of factor XII gene C46T polymorphism with cerebral venous thrombosis in the south Indian population
Measurement of anti-ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays
Platelet factor 4 platelet levels are inversely correlated with steady-state platelet counts and with platelet transfusion needs in pediatric leukemia patients
A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins
Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier
Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage
Large infarct and high mortality by cerebral ischemia in mice carrying the factor V Leiden mutation
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients: a rebuttal
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients: a reply to a rebuttal